Enzymaster focuses on the development and commercialization of enzymes for the innovative and sustainable production of API intermediates.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 30, 2020 | Series B | ¥50M | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Leimei Ruisi | — | Series B |
Caozhixing Chuangtou | — | Series B |